Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure Monitoring. [PDF]
J Clin Hypertens (Greenwich)Iwashima Y +4 more
europepmc +1 more source
You evaluation of the PARACHUTE-HF trial: role of sacubitril/valsartan compared to enalapril on outcomes in patients with heart failure from Chagas' disease. [PDF]
Heart Fail RevAbramov D +5 more
europepmc +1 more source
Sacubitril/Valsartan-induced Angioedema. [PDF]
Intern MedHiraoka Y, Nagayama K.
europepmc +1 more source
Sacubitril/valsartan as a modulator of pulmonary fibrosis: insights into Lnc-SNHG-16/miR-455 modulation and Notch/Smad-3 pathway inhibition. [PDF]
Naunyn Schmiedebergs Arch PharmacolAbdel-Nasser ZM, Zaafan MA.
europepmc +1 more source
Spatial Distribution of Astins in <i>Aster tataricus</i> and Their Production by <i>Cyanodermella asteris</i>. [PDF]
J Nat ProdBarrera-Adame DA +2 more
europepmc +1 more source
Clinical outcomes of heart failure with improved ejection fraction in patients treated with angiotensin receptor-neprilysin inhibitor. [PDF]
Korean J Intern MedKim DE +13 more
europepmc +1 more source
Effect of sacubitril/valsartan and SGLT2 inhibitors on arrhythmia burden in ICD patients. [PDF]
BMC Cardiovasc DisordÖztürk F, Yaman M.
europepmc +1 more source
Cardiac biomarkers response under angiotensin receptor-neprilysin inhibitor: a sub-analysis of the NATRIUM-HF study. [PDF]
ESC Heart FailBruno J +15 more
europepmc +1 more source
Influence of Daily Salt Intake on Blood Pressure and Atrial Natriuretic Peptide Levels in Patients Treated with Sacubitril/Valsartan. [PDF]
Intern MedSato T, Watanabe S, Aizawa Y.
europepmc +1 more source